Journal Article
. 1993 Jan;53(1).

Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas

D Muller 1 C Wolf  J Abecassis  R Millon  A Engelmann  G Bronner  N Rouyer  M C Rio  M Eber  G Methlin  
Affiliations
  • PMID: 7677979
  •     48 citations

Abstract

Matrix metalloproteinases are believed to play an important role in tumor invasion and metastasis. To examine the expression of the stromelysin 3 (ST3) gene, a new member of the matrix metalloproteinase gene family, 111 head and neck squamous cell carcinomas and 21 metastatic lymph nodes were analyzed by Northern blot. ST3 gene expression was observed in 106 carcinomas and 19 metastatic nodes, but in only 2 of 60 samples of corresponding normal tissue tested in parallel. ST3 RNA, by in situ hybridization, and ST3 protein, by immunohistochemical analysis, were specifically detected in fibroblastic cells immediately surrounding invasive cancer cells. This fibroblastic expression of the ST3 gene is characteristic among the matrix metalloproteinase genes known to be overexpressed in head and neck carcinomas, since stromelysin 2 transcripts were specifically detected in neoplastic cells, and type I collagenase transcripts in both neoplastic cells and stromal fibroblasts. Furthermore, there was a highly significant positive correlation (P < 0.0001) between ST3 RNA levels and local invasiveness by the cancer cells, suggesting that enhanced expression of the ST3 gene may contribute to the neoplastic phenotype in head and neck carcinomas.

Other Links

Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas.
I Bolon, V Gouyer, +5 authors, E Brambilla.
Am J Pathol, 1995 Nov 01; 147(5). PMID: 7485393    Free PMC article.
Role of the extracellular matrix in the degradation of connective tissue.
C Mauch, T Krieg, E A Bauer.
Arch Dermatol Res, 1994 Jan 01; 287(1). PMID: 7726628
Review.
Serum metalloproteinases and their inhibitors: markers for malignant potential.
T Baker, S Tickle, +3 authors, J Waxman.
Br J Cancer, 1994 Sep 01; 70(3). PMID: 8080738    Free PMC article.
Expression of the stromelysin-3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: a review.
P Basset, C Wolf, P Chambon.
Breast Cancer Res Treat, 1993 Jan 01; 24(3). PMID: 8435474
Review.
Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression.
C Wolf, N Rouyer, +5 authors, P Basset.
Proc Natl Acad Sci U S A, 1993 Mar 01; 90(5). PMID: 8446598    Free PMC article.
Stromelysin-3 expression promotes tumor take in nude mice.
A C Nöel, O Lefebvre, +6 authors, M C Rio.
J Clin Invest, 1996 Apr 15; 97(8). PMID: 8621777    Free PMC article.
Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans.
A E Kossakowska, S A Huchcroft, S J Urbanski, D R Edwards.
Br J Cancer, 1996 Jun 01; 73(11). PMID: 8645587    Free PMC article.
Correlated expression of matrix metalloproteinases and ets family transcription factor E1A-F in invasive oral squamous-cell-carcinoma-derived cell lines.
M Shindoh, F Higashino, +8 authors, K Fujinaga.
Am J Pathol, 1996 Mar 01; 148(3). PMID: 8774124    Free PMC article.
Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis.
J R MacDougall, L M Matrisian.
Cancer Metastasis Rev, 1995 Dec 01; 14(4). PMID: 8821095
Review.
Invasion and metastasis.
D Boyd.
Cancer Metastasis Rev, 1996 Mar 01; 15(1). PMID: 8842480
Review.
Stromelysin-3 expression in early (pT1) carcinomas and pseudoinvasive lesions of the colorectum.
J Mueller, E Mueller, +3 authors, H Höfler.
Virchows Arch, 1997 Mar 01; 430(3). PMID: 9099978
The matrix metalloproteinases and their inhibitors in pancreatic cancer. From molecular science to a clinical application.
S R Bramhall.
Int J Pancreatol, 1997 Feb 01; 21(1). PMID: 9127168
Review.
Rodent pharmacokinetic and anti-tumor efficacy studies with a series of synthetic inhibitors of matrix metalloproteinases.
O Santos, C D McDermott, R G Daniels, K Appelt.
Clin Exp Metastasis, 1997 Sep 01; 15(5). PMID: 9247252
Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck.
N Johansson, K Airola, +3 authors, V M Kähäri.
Am J Pathol, 1997 Aug 01; 151(2). PMID: 9250162    Free PMC article.
Matrix metalloproteinases. Novel targets for directed cancer therapy.
A E Yu, R E Hewitt, E W Connor, W G Stetler-Stevenson.
Drugs Aging, 1997 Sep 26; 11(3). PMID: 9303281
Review.
Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression.
A Ahmad, A Hanby, +6 authors, I Hart.
Am J Pathol, 1998 Mar 21; 152(3). PMID: 9502414    Free PMC article.
In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy.
R Masson, O Lefebvre, +9 authors, M C Rio.
J Cell Biol, 1998 Apr 29; 140(6). PMID: 9508784    Free PMC article.
The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1.
T Yoshizaki, H Sato, M Furukawa, J S Pagano.
Proc Natl Acad Sci U S A, 1998 May 09; 95(7). PMID: 9520415    Free PMC article.
Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
M Sutinen, T Kainulainen, +5 authors, T Salo.
Br J Cancer, 1998 Jul 02; 77(12). PMID: 9649139    Free PMC article.
Matrix metalloproteinase-1 is induced by epidermal growth factor in human bladder tumour cell lines and is detectable in urine of patients with bladder tumours.
J E Nutt, J K Mellon, K Qureshi, J Lunec.
Br J Cancer, 1998 Jul 31; 78(2). PMID: 9683296    Free PMC article.
Stromelysin 3 is overexpressed in human pancreatic carcinoma and regulated by retinoic acid in pancreatic carcinoma cell lines.
Z von Marschall, E O Riecken, S Rosewicz.
Gut, 1998 Nov 21; 43(5). PMID: 9824353    Free PMC article.
Matrix metalloproteinases and their inhibitors in gastric cancer.
G I Murray, M E Duncan, +2 authors, J E Fothergill.
Gut, 1998 Nov 21; 43(6). PMID: 9824606    Free PMC article.
Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy.
S L Parsons, S A Watson, +3 authors, R J Steele.
Br J Cancer, 1998 Dec 04; 78(11). PMID: 9836483    Free PMC article.
Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of alpha1-proteinase inhibitor generated by matrix metalloproteinases: a possible modulatory role in natural killer cytotoxicity.
H Kataoka, H Uchino, +3 authors, M Koono.
Am J Pathol, 1999 Feb 23; 154(2). PMID: 10027404    Free PMC article.
Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis.
R Tsukifuji, K Tagawa, A Hatamochi, H Shinkai.
Br J Cancer, 1999 Jun 11; 80(7). PMID: 10362121    Free PMC article.
PD 098059, an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinoma.
C Simon, M J Hicks, +5 authors, D Boyd.
Br J Cancer, 1999 Jul 29; 80(9). PMID: 10424744    Free PMC article.
Increased type-IV collagenase (MMP-2 and MMP-9) activity following preoperative radiotherapy in rectal cancer.
A Kumar, H M Collins, J H Scholefield, S A Watson.
Br J Cancer, 2000 Mar 25; 82(4). PMID: 10732772    Free PMC article.
Stromelysin-3 in the biology of the normal and neoplastic mammary gland.
M C Rio, O Lefebvre, +9 authors, P Basset.
J Mammary Gland Biol Neoplasia, 1996 Apr 01; 1(2). PMID: 10887496
Review.
Requirement for matrix metalloproteinase stromelysin-3 in cell migration and apoptosis during tissue remodeling in Xenopus laevis.
A Ishizuya-Oka, Q Li, +3 authors, Y B Shi.
J Cell Biol, 2000 Sep 07; 150(5). PMID: 10974004    Free PMC article.
Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: implications for lymph node metastasis.
T Shimada, H Nakamura, +6 authors, Y Okada.
Clin Exp Metastasis, 2001 Mar 10; 18(2). PMID: 11235994
Matrix metalloproteinases (MMPs) in fresh human prostate tumour tissue and organ-cultured prostate tissue: levels of collagenolytic and gelatinolytic MMPs are low, variable and different in fresh tissue versus organ-cultured tissue.
J Varani, Y Hattori, +4 authors, K J Wojno.
Br J Cancer, 2001 Apr 20; 84(8). PMID: 11308257    Free PMC article.
Keratinocyte stimulation of matrix metalloproteinase-1 production and proliferation in fibroblasts: regulation through mitogen-activated protein kinase signalling events.
S E Moon, N Bhagavathula, J Varani.
Br J Cancer, 2002 Aug 15; 87(4). PMID: 12177784    Free PMC article.
Usefulness of MMP-9/TIMP-1 in predicting tumor recurrence in patients undergoing curative surgical resection for gastric carcinoma.
Yeon Seok Seo, Jong-Jae Park, +5 authors, Young-Tae Bak.
Dig Dis Sci, 2007 Jan 24; 52(3). PMID: 17237995
Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse.
L O González, I Pidal, +7 authors, F J Vizoso.
Br J Cancer, 2007 Sep 13; 97(7). PMID: 17848954    Free PMC article.
Regulation of extracellular matrix remodeling and cell fate determination by matrix metalloproteinase stromelysin-3 during thyroid hormone-dependent post-embryonic development.
Yun-Bo Shi, Liezhen Fu, Takashi Hasebe, Atsuko Ishizuya-Oka.
Pharmacol Ther, 2007 Oct 09; 116(3). PMID: 17919732    Free PMC article.
Review.
Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells.
A K Nalla, B Gorantla, +2 authors, J S Rao.
Cancer Gene Ther, 2010 May 08; 17(9). PMID: 20448670    Free PMC article.
Efficient targeting of head and neck squamous cell carcinoma by systemic administration of a dual uPA and MMP-activated engineered anthrax toxin.
Jeffrey M Schafer, Diane E Peters, +4 authors, Thomas H Bugge.
PLoS One, 2011 Jun 10; 6(5). PMID: 21655226    Free PMC article.
Matrix metalloproteinases and their inhibitors in canine mammary tumors.
Luca Aresu, Mery Giantin, +10 authors, Mauro Dacasto.
BMC Vet Res, 2011 Jul 06; 7. PMID: 21726449    Free PMC article.
Matrix metalloproteinase-11 overexpressed in lobular carcinoma cells of the breast promotes anoikis resistance.
Tamotsu Takeuchi, Yoshihiro Adachi, Tomoko Nagayama, Mutsuo Furihata.
Virchows Arch, 2011 Jul 21; 459(3). PMID: 21773755
Expression of matrix metalloproteinase-12 is correlated with extracapsular spread of tumor from nodes with metastasis in head and neck squamous cell carcinoma.
Jin Man Kim, Hak Jun Kim, +2 authors, Yeo-Hoon Yoon.
Eur Arch Otorhinolaryngol, 2012 Aug 22; 270(3). PMID: 22907031
Claudin-4 expression is associated with tumor invasion, MMP-2 and MMP-9 expression in gastric cancer.
Tsann-Long Hwang, Li-Yu Lee, +3 authors, Chi-Ming Wu.
Exp Ther Med, 2010 Sep 01; 1(5). PMID: 22993603    Free PMC article.
Insidious changes in stromal matrix fuel cancer progression.
Fayth L Miles, Robert A Sikes.
Mol Cancer Res, 2014 Jan 24; 12(3). PMID: 24452359    Free PMC article.
Review.
Claudin-4 expression in gastric cancer cells enhances the invasion and is associated with the increased level of matrix metalloproteinase-2 and -9 expression.
Tsann-Long Hwang, Tzu-Tsung Changchien, Chee-Chan Wang, Chi-Ming Wu.
Oncol Lett, 2014 Aug 15; 8(3). PMID: 25120725    Free PMC article.
Association between MMP-12-82A/G polymorphism and cancer risk: a meta-analysis.
Luliang Liu, Jinhuan Sun, +4 authors, Fulin Guo.
Int J Clin Exp Med, 2015 Nov 10; 8(8). PMID: 26550102    Free PMC article.
Review.
Topical MMP beacon enabled fluorescence-guided resection of oral carcinoma.
Laura Burgess, Juan Chen, +2 authors, Gang Zheng.
Biomed Opt Express, 2016 May 28; 7(3). PMID: 27231609    Free PMC article.
Osteoactivin regulates head and neck squamous cell carcinoma invasion by modulating matrix metalloproteases.
Oneida A Arosarena, Eric W Barr, +3 authors, Fayez F Safadi.
J Cell Physiol, 2017 Mar 16; 233(1). PMID: 28295306    Free PMC article.
Quantitative nuclear histomorphometry predicts oncotype DX risk categories for early stage ER+ breast cancer.
Jon Whitney, German Corredor, +6 authors, Anant Madabhushi.
BMC Cancer, 2018 Jun 01; 18(1). PMID: 29848291    Free PMC article.
Gene expression of matrix metalloproteinase-1 (interstitial collagenase) and matrix metalloproteinase-3 (stromelysin-1) in basal cell carcinoma by in situ hybridization using chondroitin ABC lyase.
R Tsukifuji, Y Sakai, A Hatamochi, H Shinkai.
Histochem J, 1997 May 01; 29(5). PMID: 9184854